Find comprehensive SWOT and PESTLE research reports across industries globally

Holistic Analysis Customized Solutions Top Quality

Please Enter Correct Data! X
Thanks for downloading our report! X
Check your email for the requested analysis report.
Be sure to place support@swotandpestle.com on your approved senders list to prevent emails from going into spam.
Thanks for downloading our sample report! X
Check your email for the requested sample analysis report.
You can also download it here.
Get The Free Sample Complete
SWOT & PESTLE Analysis Report
This report is shared in order to give you an idea of what the complete SWOT & PESTLE analysis report will cover after purchase. We invest deep in order to bring you insightful research which can add tangible value to your business or academic goals. We also guarantee that you cannot find matched quality at such competitive and economic pricing.
Great quality, Affordable pricing X

As a leading strategy research portal we invest deep to produce imperial quality reports that can help corporate professionals, academicians and students take their research forward and set a benchmark for high standard business research. The cost for reports has been kept minimal to just cover our operational and maintenance costs although the mission is not to reap monetary benefits. We look forward to your support.

Johnson & Johnson SWOT & PESTLE Analysis

ID : 52257953 | Sep 2017

OVERVIEW

Name of the Company: Johnson & Johnson

Business Sector: Consumer Products, Medical equipment and Pharmaceuticals

Operating Geography: United States, North America, Global

About the Company: Johnson & Johnson is an American consumer products, medical equipment and pharmaceutical manufacturing company founded in 1886. It's headquartered in New Brunswick, New Jersey. It has 230 subsidiary companies and its products are sold in over 170 countries. It has around 125,000 employees with offices in more than 60 countries as of 2016.

Revenue: $71.9 Billion (2016)

SWOT & PESTLE Analysis

The SWOT analysis for Johnson & Johnson is presented below:
Strengths
Weaknesses
1. Revenue spread across many product categories
2. Enjoys a healthy brand equity in the minds of shareholders
3. R&D Focus and Integrated Supply Chain
1. Uncertainty of the research outcomes and regulatory approvals
2. Negative word of mouth as a result on ongoing litigations
Opportunities
Threats
1. Opportunity to cross sell products
2. Growth in revenue streams through recent acquisitions
1. Interruptions in sourcing manufacturing materials
2. Changes in tax liabilities or sudden regulatory scrutiny
Get Your Free Summary Copy of the
SWOT & PESTLE Analysis Report
Get the summary SWOT & PESTLE.com report delivered straight to your email inbox for free.
Our insightful and holistic reports have helped corporate,academia and researchers to take their research forward. Like us on Facebook to stay updated with the latest published SWOT & PESTLE Report.

Safe and secure payments

* By clicking on "Buy Now" you agree to accept our "Terms and Conditions."

Strengths

1. Revenue spread across many product categories: Their revenue sources are broadly spread across pharmaceuticals, consumer products and medical devices. The sales in the Consumer segment were $13.3 billion in 2016. The sales in the Pharmaceutical segment were $33.5 billion in 2016. The sales in the Medical Devices segment were $25.1 billion in 2016.

2. Enjoys a healthy brand equity in the minds of shareholders: The company has $72 billion in revenue and coupled with its solid balance sheet across the last 4 quarters makes the New Jersey-based health care giant the first choice of many mutual fund portfolios. Johnson & Johnson shares have been on a roll for five years, doubling in price from about $67 in August 2012 to $133 and change in 2017. The shares are up 16 percent so far in 2017.

3. R&D Focus and Integrated Supply Chain: Research activities represent a significant part of the Company’s businesses. The Company remains committed to investing in research and development with the aim of delivering high quality and innovative products. In terms of worldwide costs of research and development activities, 9.1 billion dollars were spent in 2016, 9 billion dollars were spent in 2015 and 8.5 billion dollars were spent in 2014. Research facilities are located in the United States, Canada, India, China, Netherlands, France, Switzerland, Germany, Israel, Belgium, Japan, Singapore, Brazil and Britain. They aim to utilize operational efficiencies and a robust supply chain to ensure operating margins are at benchmark levels.

Weaknesses

1. Uncertainty of the research outcomes and regulatory approvals: Challenges and uncertainties is a given in innovation and development of improved products and services on which the company’s continued growth and profits depend, including uncertainty of clinical experiments, obtaining regulatory approvals from the government of various countries, health plans covered across geographies and customer access to quality healthcare for continued commercial success of the company. Challenges to the company’s ability to obtain and protect patents and other intellectual property rights for new and existing products and services across the markets of the world remains a weakness.

2. Negative word of mouth as a result on ongoing litigations: Over the last few years, Johnson & Johnson has been fighting many lawsuits over its talc-based consumer products. In the past decade, J&J has had to pay millions of dollars as damages to plaintiffs who sued the company. Some of the litigations over the years are illegal marketing of a drug called Risperdal, lawsuits by shareholders, defective pharmaceutical drug recalls and bribery issues.

Opportunities

1. Opportunity to cross sell products: Johnson & Johnson has a multitude of products available across pharmaceuticals, medical devices and consumer products. As a result, it can diversify its cross sell offerings on retail shelves. A consumer is more likely to buy multiple Johnson & Johnson products in a single transaction because of this opportunity of being cross marketed at a retail level.

2. Growth in revenue streams through recent acquisitions: In the last year alone, Johnson & Johnson completed 14 acquisitions and major licensing deals including 8 divestitures, positioning themselves for sustainable growth and profit for the next few years. Their acquisition of Abbott Medical Optics, which happened in the beginning of 2017, shows their flexibility to invest in diverse areas of specializations across the spectrum of health care. All in all, the corporation consists of 230 subsidiary companies with businesses spread across 60 countries. Good management in these newly acquired businesses can boost their bottom line. As a result, the opportunity to expand the business and thrive is immense in the near future.

Threats

1. Interruptions in sourcing manufacturing materials: Johnson & Johnson has 119 manufacturing facilities that rely on sourcing of high quality raw materials from across the globe to make its medical and consumer products. In the past, there have been interruptions and delays in receiving these materials from suppliers due to various supply chain or logistical difficulties. Such problems in sourcing materials have resulted in product shortages in the past. Sales by volume have taken sudden dips. Without a doubt, such problems can also lead to a dent in the reputation and trust associated with the brand.

2. Changes in tax liabilities or sudden regulatory scrutiny: Government authorities and regulatory bodies are always on the lookout to random examinations of various drugs. The process is not always transparent and a small compliance testing mistake on the part of the investigating agency could lead to serious implications of the company stock apart from unnecessary interruption in production. Johnson and Johnson are present in numerous countries and each of them have a different tax environment. A sudden change in tax regulations can adversely impact operational costs and balance sheet bottom line.

To get the complete detailed SWOT report on Johnson and Johnson please mail us at: support@swotandpestle.com. or contact us here.

Safe and secure payments

* By clicking on "Buy Now" you agree to accept our "Terms and Conditions."

The PESTLE / PESTEL analysis for Johnson & Johnson is presented below:
Political
Economical
1. Political Action Committee and other political contributions
2. Regular tab on the local political environment
1. Changes in Foreign Currency Exchange rates
2. Currency devaluation and Inflation risks
Social
Technological
1. Tackling health scares via research and education1. Continued use of new technology in research and development
Legal
Environmental
1. Expiration or challenge of existing patents by rival companies1. Thrust on focusing its efforts towards a green Earth
Get Your Free Summary Copy of the
SWOT & PESTLE Analysis Report
Get the summary SWOT & PESTLE.com report delivered straight to your email inbox for free.
Our insightful and holistic reports have helped corporate,academia and researchers to take their research forward. Like us on Facebook to stay updated with the latest published SWOT & PESTLE Report.
Safe and secure payments

* By clicking on "Buy Now" you agree to accept our "Terms and Conditions."

Political

1. Political Action Committee and other political contributions: In US, Johnson and Johnson has a Political Action Committee that is consistent with United States Federal and State laws that allows any US citizen to voice and change public policy with respect to health issues. Johnson and Johnson also regularly makes generous donations to support candidates in election campaigns who are championing the cause of affordable quality health standards.

To get the complete detailed PESTLE report on Johnson and Johnson please mail us at: support@swotandpestle.com. or contact us here.

Safe and secure payments

* By clicking on "Buy Now" you agree to accept our "Terms and Conditions."

Copyrights and Disclaimer

Johnson and Johnson SWOT and PESTLE analysis has been conducted by Sohum Mishra and reviewed by senior analysts from Barakaat Consulting.

Copyright of Johnson and Johnson SWOT and PESTLE Analysis is the property of Barakaat Consulting. Please refer to the Terms and Conditions for usage guidelines.

The text on www.swotandpestle.com are the property of Barakaat Consulting. While every attempt has been made to ensure completeness, accuracy and reliability of the analysis, Barakaat Consulting and its associate websites cannot be held responsible for omissions or errors in our pages or any links on any of our pages. Analyses published by us above may not totally reflect the company's opinions, reader's discretion is advised. Users have the right to choose the products that suits them the most.